Pharmaceuticals


	Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. In 2011, we invested $5.1 billion in pharmaceutical research and development for new medicines to treat these and many other diseases. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives. The Pharmaceutical segment’s broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience & pain, and oncology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use. Janssen R&D LLC As one of the Janssen Pharmaceutical Companies, our strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. We leverage our world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism; immunology; infectious diseases and vaccines; neuroscience, and oncology. Janssen Pharmaceuticals Inc. Providing medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. Janssen Healthcare Innovation JHI is a newly established team within the Janssen Research & Development, LLC. We are expanding the company’s offerings of healthcare services and solutions by acquiring companies and programs, and establishing partnerships and collaborations both internally and externally. Our goal is to empower healthcare consumers and modernize healthcare delivery Janssen Diagnostics Janssen Diagnostics is committed to saving and improving patients’ lives through the integration and delivery of differentiating diagnostic and health IT solutions into world-class personalized disease management. Building beyond our joint legacy of world-class diagnostic interventions, our mission is to invest and partner in driving revolutionary diagnostic solutions in oncology, infectious diseases, central nervous system diseases, immunologic and cardiovascular disease. Veridex, LLC Dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.

Johnson & Johnson

Home > Our Company > Company Structure

Pharmaceuticals

	Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. In 2011, we invested $5.1 billion in pharmaceutical research and development for new medicines to treat these and many other diseases. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives. The Pharmaceutical segment’s broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience & pain, and oncology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use. Janssen R&D LLC As one of the Janssen Pharmaceutical Companies, our strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. We leverage our world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism; immunology; infectious diseases and vaccines; neuroscience, and oncology. Janssen Pharmaceuticals Inc. Providing medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. Janssen Healthcare Innovation JHI is a newly established team within the Janssen Research & Development, LLC. We are expanding the company’s offerings of healthcare services and solutions by acquiring companies and programs, and establishing partnerships and collaborations both internally and externally. Our goal is to empower healthcare consumers and modernize healthcare delivery Janssen Diagnostics Janssen Diagnostics is committed to saving and improving patients’ lives through the integration and delivery of differentiating diagnostic and health IT solutions into world-class personalized disease management. Building beyond our joint legacy of world-class diagnostic interventions, our mission is to invest and partner in driving revolutionary diagnostic solutions in oncology, infectious diseases, central nervous system diseases, immunologic and cardiovascular disease. Veridex, LLC Dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. In 2011, we invested $5.1 billion in pharmaceutical research and development for new medicines to treat these and many other diseases. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

The Pharmaceutical segment’s broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience & pain, and oncology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use.

Janssen R&D LLC
As one of the Janssen Pharmaceutical Companies, our strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. We leverage our world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism; immunology; infectious diseases and vaccines; neuroscience, and oncology.

Janssen Pharmaceuticals Inc.
Providing medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.

Janssen Healthcare Innovation
JHI is a newly established team within the Janssen Research & Development, LLC. We are expanding the company’s offerings of healthcare services and solutions by acquiring companies and programs, and establishing partnerships and collaborations both internally and externally. Our goal is to empower healthcare consumers and modernize healthcare delivery

Janssen Diagnostics
Janssen Diagnostics is committed to saving and improving patients’ lives through the integration and delivery of differentiating diagnostic and health IT solutions into world-class personalized disease management. Building beyond our joint legacy of world-class diagnostic interventions, our mission is to invest and partner in driving revolutionary diagnostic solutions in oncology, infectious diseases, central nervous system diseases, immunologic and cardiovascular disease.

Veridex, LLC
Dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients through earlier disease detection and may enable personalized strategies to help improve patient management and outcomes

Employees